MedPage Today) — Tirzepatide (Mounjaro) improved glucose control and body mass index (BMI) in children with type 2 diabetes who were inadequately controlled with metformin and basal insulin, the phase III SURPASS-PEDS trial showed.
Among 99…
Mounjaro Found Safe, Effective in Kids With Type 2 Diabetes

Leave a Comment Leave a Comment